Purchase U-47700
Discount program, second order - 5%OFF, third order - 7% OFF
With us securely! - re-shipment guarantees.
We always offer new legal products of impeccable quality.
Please make sure that the product is legal in your country and not under control before ordering.
We do not sell pharmaceutical products or controlled products.
Where to buy U-47700 for sale
Opioid medications have been integral to human culture for generations, acting as potent relievers for people in need. U-47700 is one of a new series of hazardous and potentially lethal medications spawned by the emergence of synthetic opioids.
The opioid analgesic U-47700, sometimes known as pink heroin, pinky, and pink, was created by Upjohn in the 1970s. This synthetic opioid was developed through trial and error, with Upjohn attempting to optimize the binding moieties that provide the highest action. In animal models, the outcome was a medication with approximately seven-and-a-half times the potency of morphine.
Although U-47700 began as a good analgesic, it rapidly became a public health concern. The substance has been prohibited in several nations worldwide because it has been related to many overdose deaths. In this post, we'll take a deeper look at the history of U-47700 and why this medicine is so deadly.
The History of U-47700
U-47700 is a structural isomer of the earlier opioid AH-7921, created by the same team at Upjohn. This medication was the outcome of years of effort focused on understanding the quantitative structure-activity connection of the scaffold. Upjohn undertook considerable research and published over a dozen patents on similar compounds, each of which optimized one moiety to identify the most active chemical.
Despite the substantial study and testing, U-47700 became an immediate issue for health experts. The potency of this medication was determined to be substantially greater than previous synthetic opioids, and tales of overdose deaths began to arise. As a result, several nations worldwide prohibited the medication, including the United States, which placed it on Schedule I of forbidden substances.
The Dangers of U-47700
U-47700 is a powerful substance that has been related to many overdose deaths. This drug's strength makes it very hazardous, as even small doses can result in severe injury or death. In addition to the risk of overdose, U-47700 can potentially cause a variety of other health concerns, including:
-Nausea and vomiting
-Respiratory depression
-Confusion and disorientation
-Seizures
-Coma and death
The Future of U-47700
U-47700's future is unknown, as the drug continues to be outlawed in most nations and is well regarded as a deadly poison. Despite this, there is a possibility that the drug may continue to be created and marketed illegally, putting more individuals in danger.
We must continue to educate the public on the hazards of U-47700 to limit the risk of damage associated with this substance. This involves increasing awareness about the dangers of synthetic opioids and the necessity for improved regulation of these substances.
To prepare the content, the following materials were used:
- FDA Substance Registration System
- Hazardous Substances Data Bank. National Library of Medicine. 28 August 2008. Retrieved 22 August 2014. 3,4-Methylenedioxymethamphetamine
- Liver transplant modulates gut microbial dysbiosis and cognitive function in cirrhosis. PDF . By HoChong Gilles, Scott C Matherly, Mohammed S Siddiqui, Puneet Puri...
- Differential impact of hyponatremia and hepatic encephalopathy on health-related quality of life and brain metabolite abnormalities in cirrhosis . By Jasmohan Bajaj
- An overview of alcohol and other drug issues
- Medicating the mind: a Kantian analysis of overprescribing psychoactive drugs B A Manninen
- The pharmacological basis of opioids Carla Ghelardini, Lorenzo Di Cesare Mannelli and Enrica Bianchi
- Ask Dr. Shulgin Online ARCHIVE: June 3, 2004
- Inhibition of plasma membrane monoamine transporters by β-ketoamphetamines. Nicholas V Cozzi, Michael KSievert, Alexander T Shulgin, Peyton JacobIII, Arnold Eruoho
- Schedules of Controlled Substances: Placement of Methylone Into Schedule I
- Bioanalysis of new designer drugs. Wohlfarth A, Weinmann W.
- New Psychoactive Substances (including synthetic cannabinoids, mephedrone, and more)
- Future Synthetic Drugs of Abuse. Donald A. Cooper. Drug Enforcement Administration McLean, Virginia
- Designer drugs: a medicinal chemistry perspective. F. Ivy Carroll Anita H. Lewin S. Wayne Mascarella Herbert H. Seltzman P. Anantha Reddy
- Synthetic cannabinoids in Europe
- Pharmacological Effects of MDMA in Man. By Enno Freye
- Drug Use in Relation to Outcome of Mammography Screening. von Euler-Chelpin M, Wu W, Vejborg and Lynge E
- DEA Drug Scheduling
- Electrophysiological Effects of Trace Amines on Mesencephalic Dopaminergic Neurons.Ada Ledonne, Nicola Berretta, Alessandro Davoli, Giada Ricciardo Rizzo, Giorgio Bernardi and Nicola Biagio Mercuri
- Electrophysiological evidence for a reciprocal interaction between amphetamine and cocaine-related drugs on rat midbrain dopaminergic neurons.Scarponi M, Bernardi G, Mercuri NB.
- Overdose of Drugs for Attention-Deficit Hyperactivity Disorder: Clinical Presentation, Mechanisms of Toxicity, and Management. Henry A. Spiller, author Hannah L. Hays Alfred Aleguas.
- Dose-dependent effectiveness of wheel running to attenuate cocaine-seeking: impact of sex and estrous cycle in rats. Peterson AB, Hivick DP, Lynch WJ.r.
- FDA Drug Safety Communication: Safety Review Update of Medications used to treat Attention-Deficit/Hyperactivity Disorder (ADHD) in children and young adults
- ADHD Medications and Risk of Serious Cardiovascular Events in Young and Middle-aged Adults
- Controlled Substances Act
- The Art of Drug Synthesis (Wiley Series on Drug Synthesis)
- Cannabis: domestic cultivation widespread
- A review of the influence of functional group modifications to the core scaffold of synthetic cathinones on drug pharmacokinetics
